It is acknowledged widely that the binding of RANK and RANKL activates the NF-κB pathway, which plays an important role in the stem-like cell maintaining process, cellular proliferation and invasion, epithelial to mesenchymal transition process, and resistance to chemotherapy and radiotherapy in glioblastoma [29]. The gene discussed is NFKB1; the disease is glioblastoma.